Who founded Inipharm?

Inipharm was founded by Brian Farmer, Heather Hsu, PhD, Michael Gallatin, PhD.

Who are Inipharm's investors?

Inipharm's investors include 5AM Ventures, Frazier Life Sciences, Frazier Healthcare Partners, Wu Capital.

Inipharm

6 employees on LinkedIn · 4 known investors

Find your way into Inipharm

Paths you didn't know you had: your email and LinkedIn already hold routes to the Inipharm team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.

Biotech Healthtech Medical Devices

Founders & leadership

Brian Farmer Co-founder · Chief Executive OfficerEntrepreneur-in-Residence at Frazier Life Sciences

Heather Hsu, PhDCo-Founder, Chief Scientific Officer

Michael Gallatin, PhDCo-Founder, SAB Chair

Chuhan Chung Chief Medical OfficerChuhan Chung is a physician-scientist with experience in clinical drug development and translational science; they previously held an academic position as a clinician-scientist with a funded laboratory focused on target validation and translational research.

Investors · 4

5AM Ventureslisted by 5AM VenturesSan Francisco · $100K – $4M

How we know: 5AM Ventures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · Not right? Tell us

Frazier Healthcare PartnersreportedSeattle · $50M – $400M

How we know: funding news · Not right? Tell us

Wu Capitalreported

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountSeries ANov 2020
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Inipharm.

Frequently asked questions

What does Inipharm do?: Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
Who founded Inipharm?: Inipharm was founded by Brian Farmer, Heather Hsu, PhD, Michael Gallatin, PhD.
Who are Inipharm's investors?: Inipharm's investors include 5AM Ventures, Frazier Life Sciences, Frazier Healthcare Partners, Wu Capital.